Literature DB >> 20549017

Legal suits: pharmaceutical industry strategies to introduce new drugs in the Brazilian public healthcare system.

Ana Luiza Chieffi1, Rita de Cássia Barradas Barata.   

Abstract

OBJECTIVE: To assess the distribution rate of legal suits according to drug (manufacturer), prescribing physician, and attorney filing the lawsuit.
METHODS: A descriptive study was carried out to assess the lawsuits in the São Paulo State (Southeastern Brazil) courts registry in 2006, and amounts spent in complying with these lawsuits, and total costs with medication thus resulting.
RESULTS: In 2006, the São Paulo State Administration spent 65 million Brazilian reais in compliance with court decisions to provide medication to approximately 3,600 individuals. The total cost of the medication was 1.2 billion Brazilian reais. In the period studied, 2,927 lawsuits were examined. These lawsuits were filed by 565 legal professionals, among which 549 were attorneys engaged by private individuals (97.17% of the total legal professionals). The drugs scope of the lawsuits had been prescribed by 878 different physicians. By assessing the number of lawsuits filed per attorney, it was found that 35% of them were brought before the courts by 1% of them.
CONCLUSIONS: The data related to the lawsuits and to the medication classified according to manufacturer, show that a small number of attorneys is responsible for the largest number of lawsuits filed to obtain these drugs. The finding that more than 70% of the lawsuits filed for certain drugs are the responsibility of one single attorney, may suggest a close connection between this professional and the manufacturer.

Mesh:

Substances:

Year:  2010        PMID: 20549017     DOI: 10.1590/s0034-89102010000300005

Source DB:  PubMed          Journal:  Rev Saude Publica        ISSN: 0034-8910            Impact factor:   2.106


  6 in total

1.  Judicial demand of medications through the Federal Justice of the State of Paraná.

Authors:  Renato Mitsunori Nisihara; Ana Carolina Possebom; Luiza de Martino Cruvinel Borges; Ana Claudia Athanasio Shwetz; Fernanda Francis Benevides Bettes
Journal:  Einstein (Sao Paulo)       Date:  2017 Jan-Mar

2.  The case of eculizumab: litigation and purchases by the Brazilian Ministry of Health.

Authors:  Rosângela Caetano; Paulo Henrique Almeida Rodrigues; Marilena C Villela Corrêa; Pedro Villardi; Claudia Garcia Serpa Osorio-de-Castro
Journal:  Rev Saude Publica       Date:  2020-03-02       Impact factor: 2.106

3.  The Judicialization of Health and the Quest for State Accountability: Evidence from 1,262 Lawsuits for Access to Medicines in Southern Brazil.

Authors:  João Biehl; Mariana P Socal; Joseph J Amon
Journal:  Health Hum Rights       Date:  2016-06

4.  Health and Ethical Consequences of Outsourcing Pivotal Clinical Trials to Latin America: A Cross-Sectional, Descriptive Study.

Authors:  Núria Homedes; Antonio Ugalde
Journal:  PLoS One       Date:  2016-06-23       Impact factor: 3.240

Review 5.  Prioritization of strategies to approach the judicialization of health in Latin America and the Caribbean.

Authors:  Carlos Eduardo Pinzón-Flórez; Evelina Chapman; Leonardo Cubillos; Ludovic Reveiz
Journal:  Rev Saude Publica       Date:  2016-09-01       Impact factor: 2.106

6.  Data Sources for Drug Utilization Research in Brazil-DUR-BRA Study.

Authors:  Lisiane Freitas Leal; Claudia Garcia Serpa Osorio-de-Castro; Luiz Júpiter Carneiro de Souza; Felipe Ferre; Daniel Marques Mota; Marcia Ito; Monique Elseviers; Elisangela da Costa Lima; Ivan Ricardo Zimmernan; Izabela Fulone; Monica Da Luz Carvalho-Soares; Luciane Cruz Lopes
Journal:  Front Pharmacol       Date:  2022-01-14       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.